| Peritonitis due to Leclercia adecarboxylata in a Patient Receiving Automated Peritoneal Dialysis |
| Heon Nam Lee, M.D.1, Jin‐woong Park, M.D.1, Hyung Soo Kim, M.D.1, Soon‐ho Park, M.D.3, Jae Hyun Chang, M.D.1,2, Woo Kyung Chung, M.D.1,2, Hyun Hee Lee, M.D.1,2, Yiel Hae Seo, M.D.3 and Sejoong Kim, M.D.1,2 |
Department of Internal Medicine1
Laboratory of Molecular Nephrology2 and Laboratory Medicine3
Gachon University of medicine and science, Incheon, Korea |
| 증례 : 자동 복막투석 환자에서 Leclercia adecarboxylata로 인한 복막염 1예 |
| 이헌남1, 박진웅1, 김형수1, 박순호3, 장제현1,2, 정우경1,2, 이현희1,2, 서일혜3, 김세중1,2 |
| 가천의대 길병원 내과학교실1, 분자신장학교실2, 진단검사의학과3 |
|
|
| Abstract |
|
Peritonitis in patients undergoing peritoneal dialysis is a major complication and the leading cause of peritoneal dialysis failure. Leclercia adecarboxylata is a motile, gram-negative, facultative anaerobic bacillus of the Enterobacteriaceae family. These bacteria are uncommon pathogen, and rarely isolated from environmental and clinical specimens. Some cases have been reported about peritonitis due to Leclercia adecarboxylata in a patient receiving continuous ambulatory peritoneal dialysis (CAPD). However, there has never been any report about peritonitis in a patient receiving automated peritoneal dialysis (APD). We have isolated Leclercia adecarboxylata from peritoneal fluid in a patient receiving APD, and the patient completely recovered with 14-day treatment of intraperitoneal antibiotics without catheter removal. |
| Key Words:
Enterobacteriaceae, Peritoneal dialysis, Peritonitis |
|
PDF Links
Download Citation
